In attempt to explore the molecular mechanism driven by TRIM9 for promoting bladder cancer development, we further evaluated the transcriptome expression of TRIM9-high patients (n = 148) compared to TRIM-low group (n = 148). Here, TRIM9 is linked to urinary bladder cancer.